摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chlorotetrazolo[1,5-a]pyrazine | 77888-19-8

中文名称
——
中文别名
——
英文名称
8-chlorotetrazolo[1,5-a]pyrazine
英文别名
——
8-chlorotetrazolo[1,5-a]pyrazine化学式
CAS
77888-19-8
化学式
C4H2ClN5
mdl
MFCD09909755
分子量
155.546
InChiKey
OAPDEASJMBJHRA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    101-104 °C
  • 密度:
    1.97±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    56
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Nitrile Ylides: Allenic and Propargylic Structures from Pyrazinylnitrenes. Experimental and Theoretical Characterization
    摘要:
    Matrix photolysis of 2-pyrazinyl azides/tetrazolo[1,5-a]pyrazines generates nitrile ylides 15 via pyrazinylnitrenes 13 and triazacycloheptatetraenes 14. The nitrile ylides 15 are characterized by IR spectroscopy in conjunction with harmonic and anharmonic vibrational frequency calculations. The nitrile ylides exist in the matrices in the Z,Z-conformations in which they are born. Substitution on the nitrile carbon of nitrile ylides has a profound effect on their structure. Even different conformers of the same molecule can have differences up to 200 cm(-1) in the IR absorptions of the ylide moieties. Nitrite ylides 15a and 15b (R = H or Cl, R' = H) have allenic structures (15 Allenic). Nitrile ylide 15c (R = R' = CH3) has a distinctly propargylic structure (15 Propargylic) in the experimentally observed Z,Z-conformation.
    DOI:
    10.1021/jo500002r
  • 作为产物:
    描述:
    3-氯-2-肼-1,2-二氢吡嗪盐酸盐溶剂黄146 、 sodium nitrite 作用下, 以 为溶剂, 反应 1.0h, 以73%的产率得到8-chlorotetrazolo[1,5-a]pyrazine
    参考文献:
    名称:
    [EN] HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
    [FR] INHIBITEURS HÉTÉROCYCLIQUES DE RÉCEPTEURS DE L'HISTAMINE DESTINÉS AU TRAITEMENT DE MALADIE
    摘要:
    公开号:
    WO2011112766A3
点击查看最新优质反应信息

文献信息

  • Transformations of 8-substituted tetrazolo[1,5-a]pyrazines
    作者:P. A. Slepukhin、G. L. Rusinov、S. S. Dedeneva、V. N. Charushin
    DOI:10.1007/s11172-007-0056-6
    日期:2007.2
    The reactions of 8-chlorotetrazolo[1,5-a]pyrazine with N-, O-, and S-nucleophiles involve the ipso substitution of the chlorine atom. Heating of this compound with benzotriazole or phenyltetrazole results in elimination of the nitrogen molecule from one of the tetrazole rings to form new annelated azapentalenes.
    8-四唑并[1,5-a]吡嗪与N-、O-和S-亲核试剂的反应涉及原子的ipso取代。将该化合物与苯并三唑或苯基四唑一起加热导致氮分子从四唑环之一中消除,形成新的退火氮杂戊烯
  • HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
    申请人:Borchardt Allen
    公开号:US20110237565A1
    公开(公告)日:2011-09-29
    The present invention relates to compounds and methods which may be useful as inhibitors of H 4 R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
    本发明涉及化合物和方法,可用作H4R的抑制剂,用于治疗或预防炎症、自身免疫、过敏和眼部疾病。
  • Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease
    申请人:Borchardt Allen
    公开号:US08569300B2
    公开(公告)日:2013-10-29
    The present invention relates to substituted tetrazolo[1,5-a]pyrazine compounds for Formula IX: as well as pharmaceutical compositions thereof, which may be useful as inhibitors of H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
    本发明涉及代替的四唑[1,5-a]吡嗪化合物,化学式为IX:以及其制药组合物,可用作H4R的抑制剂,用于治疗或预防炎症、自身免疫、过敏和眼部疾病。
  • Heterocyclic inhibitors of histamine receptors for the treatment of disease
    申请人:Chen Pingyun
    公开号:US08859550B2
    公开(公告)日:2014-10-14
    The present invention relates to salts, hydrates, and polymorphs of bicyclic heteroaryl compounds, and pharmaceutical compositions thereof, which may be useful as inhibitors of H4R for the treatment or prevention of diseases including allergic rhinitis.
    本发明涉及双环杂芳基化合物的盐、合物和多晶形式,以及其制备的药物组合物,可用于治疗或预防包括过敏性鼻炎在内的疾病,可能对H4R的抑制剂有用。
  • [EN] HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DES RÉCEPTEURS À L'HISTAMINE UTILISABLES EN VUE DU TRAITEMENT DE MALADIES
    申请人:KALYPSYS INC
    公开号:WO2013039785A3
    公开(公告)日:2013-07-11
查看更多